
Sign up to save your podcasts
Or


In this episode Tom Lehmann talks with Shalu Chada, Managing Director and Accenture's Life Sciences Technology Lead, to discuss the 2022 Life Sciences Technology Vision and how each of the report's four trends ingrained in the metaverse are reshaping biopharma experiences of the future.
By Accenture5
1818 ratings
In this episode Tom Lehmann talks with Shalu Chada, Managing Director and Accenture's Life Sciences Technology Lead, to discuss the 2022 Life Sciences Technology Vision and how each of the report's four trends ingrained in the metaverse are reshaping biopharma experiences of the future.

68 Listeners

14 Listeners

1 Listeners

1 Listeners

4 Listeners

8 Listeners

13 Listeners

16 Listeners

0 Listeners